Tolevamer

DB01344ApprovedSmall moleculePotassium BinderPotassium-removing Agents

Tolevamer is a potassium-binding resin used in the treatment of hyperkalemia. Sodium polystyrene sulfonate is a medication used to treat abnormally high potassium levels.

Mechanism
Curator reviewed
Primary indication
Used to treat abnormally high potassium levels.Curator reviewed · 1 structured indication
First approval
Canada, 1997 · United States, 1958
Also known as
Polystyrene sulfonate · Polystyrene sulfonic acid · polystyrenesulfonic acid
Brand names
  • Kayexalate
  • Kionex
  • Resonium Calcium
  • Solystat

Resolves to

What you can answer from here — as of July 17, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
66Drug interactionsStructured to mechanism, not free text
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
102Marketed productsAcross 9 countries and 58 labellers
Sign in
1ATC codeIncluding every combination product, plus 22 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tolevamer, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account